Medigene AG (XTER:MDG1)

€ 1.126 0.046 (4.26%) Market Cap: 15.92 Mil Enterprise Value: 4.44 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 46/100

Q2 2024 Medigene AG Earnings Call Transcript
Aug 14, 2024

€2.32

Earnings
Q4 2023 Medigene AG Earnings Call Transcript
Mar 28, 2024

€4.01 (-0.47%)

Earnings
Q2 2023 Medigene AG Earnings Call Transcript
Aug 17, 2023

€3.61 (+1.06%)

Earnings
Medigene AG to Discuss TCR-T Therapy for Solid Tumors Transcript
Jun 20, 2023
Q4 2022 Medigene AG Earnings Call Transcript
Mar 29, 2023

€3.54 (-2.36%)

Earnings
Medigene AG to Discuss Updated Corporate Strategy Call Transcript
Nov 16, 2022
Q2 2022 Medigene AG Earnings Call Transcript
Aug 03, 2022

€4.77 (+1.21%)

Earnings
Q4 2021 Medigene AG Earnings Call Transcript
Mar 23, 2022

€6.8 (+11.01%)

Earnings
Q2 2021 Medigene AG Earnings Call Transcript
Aug 12, 2021

€7.41

Earnings
Q4 2020 Medigene AG Earnings Call Transcript
Mar 25, 2021

€7.13 (-1.70%)

Earnings

Q4 2023 Medigene AG Earnings Call Transcript

Mar 28, 2024 / 02:00PM GMT

Release Date Price: €4.01 (-0.47%)

Transcript

Operator

Ladies and gentlemen, welcome to the Medigene AG full-year 2023 earnings call and live webcast. I am Sandra, the chorus call operator. (Operator Instructions)

At this time, it's my pleasure to hand over to Pamela Keck. Please go ahead.

Pamela Keck

Medigene AG - VP, IR and Corporate Communications

Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene. Today, we announced financial results for the year ended December 31, 2023. You can access the press release on the Investor Relations page of our website at medigene.com.

Before we get started, let's quickly run through the forward-looking statements. Please note that as a part of our discussion today, management will be making forward-looking statements. Also, we believe our expectations are based on reasonable assumptions.

By their very nature, forward-looking statements involve risks and uncertainties that may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.